Novo Nordisk

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity.
Company Growth (employees)
Type
Public
HQ
Bagsvaerd, DK
Founded
1923
Size (employees)
41,971 (est)+4%
Novo Nordisk was founded in 1923 and is headquartered in Bagsvaerd, DK

Key People at Novo Nordisk

Lars Rebien Sørensen

Lars Rebien Sørensen

President & Chief Executive Officer
Jesper Brandgaard

Jesper Brandgaard

EVP and Chief Financial Officer
Maziar Mike Doustdar

Maziar Mike Doustdar

EVP of International Operations
Lars Fruergaard Jørgensen

Lars Fruergaard Jørgensen

EVP Corporate Developemnt

Novo Nordisk Office Locations

Novo Nordisk has offices in Bagsvaerd, Plainsboro, Mississauga, Mainz and in 132 other locations
Bagsvaerd, DK (HQ)
Novo Allé
Tokyo, JP
Meiji Yasuda Seimei Bldg. 2 1 1, Marunouchi, Chiyoda Ku
Beijing, CN
18 F, East Tower, World Financial Center, No. 1 East 3rd Ring Middle Road, Chaoyang District
Bangalore, IN
Plot No.32, 47 50, Epip Area, Whitefield
Av Alphen Aan Den Rijn, NL
Flemingweg 18
Mainz, DE
Brucknerstrasse 1
Mississauga, CA
300 2680 Skymark Avenue, Floor 3
Plainsboro, US
800 Scudders Mill Road

Novo Nordisk Data and Metrics

Novo Nordisk Financial Metrics

Numbers are in $, USD

Market capitalization (26-May-2017)

104 b

Closing share price (26-May-2017)

41.9
Novo Nordisk's current market capitalization is $104 b.

Novo Nordisk Operating Metrics

FY, 2015FY, 2016

Phase III Trials

63

Projects in R&D Pipeline

1917

Patients Reached

26.8 m

Novo Nordisk Market Value History

Novo Nordisk Job Categories

Novo Nordisk Median Salaries

Source: 33 public H-1B filings from Novo Nordisk

Novo Nordisk Online and Social Media Presence

Novo Nordisk News and Updates

Novo Nordisk Company Life and Culture

You may also be interested in